CARRATU', Pierluigi
 Distribuzione geografica
Continente #
NA - Nord America 10.413
AS - Asia 3.921
EU - Europa 3.160
SA - Sud America 1.020
Continente sconosciuto - Info sul continente non disponibili 332
AF - Africa 148
OC - Oceania 11
Totale 19.005
Nazione #
US - Stati Uniti d'America 10.266
SG - Singapore 1.656
CN - Cina 932
IT - Italia 923
BR - Brasile 808
HK - Hong Kong 494
SE - Svezia 466
DE - Germania 361
RU - Federazione Russa 330
UA - Ucraina 251
FI - Finlandia 240
FR - Francia 214
VN - Vietnam 211
GB - Regno Unito 184
IN - India 128
BD - Bangladesh 81
AR - Argentina 70
IQ - Iraq 61
CA - Canada 60
ID - Indonesia 57
MX - Messico 45
TR - Turchia 44
ZA - Sudafrica 37
EC - Ecuador 36
CO - Colombia 35
JP - Giappone 34
IE - Irlanda 31
UZ - Uzbekistan 31
VE - Venezuela 31
SA - Arabia Saudita 29
ES - Italia 27
PK - Pakistan 25
BE - Belgio 24
CI - Costa d'Avorio 23
PL - Polonia 22
MA - Marocco 20
CZ - Repubblica Ceca 19
NL - Olanda 18
PH - Filippine 17
MY - Malesia 16
AT - Austria 15
EG - Egitto 14
TN - Tunisia 14
AE - Emirati Arabi Uniti 13
KE - Kenya 12
PE - Perù 12
NP - Nepal 11
PY - Paraguay 11
DZ - Algeria 9
JM - Giamaica 9
JO - Giordania 9
CR - Costa Rica 8
AU - Australia 7
IL - Israele 7
KZ - Kazakistan 7
LB - Libano 7
AZ - Azerbaigian 6
CH - Svizzera 6
CL - Cile 6
IR - Iran 6
BH - Bahrain 5
BO - Bolivia 5
ET - Etiopia 5
HN - Honduras 5
LT - Lituania 5
NI - Nicaragua 5
OM - Oman 5
PA - Panama 5
UY - Uruguay 5
NG - Nigeria 4
PS - Palestinian Territory 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
AL - Albania 3
EU - Europa 3
GE - Georgia 3
KG - Kirghizistan 3
QA - Qatar 3
RS - Serbia 3
SY - Repubblica araba siriana 3
AM - Armenia 2
AO - Angola 2
BG - Bulgaria 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
GR - Grecia 2
KR - Corea 2
ML - Mali 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
RO - Romania 2
SC - Seychelles 2
TH - Thailandia 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
BS - Bahamas 1
EE - Estonia 1
GA - Gabon 1
GI - Gibilterra 1
Totale 18.661
Città #
Fairfield 1.013
Ashburn 958
Woodbridge 863
Singapore 855
Chandler 831
San Jose 590
Jacksonville 570
Houston 554
Hong Kong 494
Seattle 429
Milan 391
Nyköping 362
Ann Arbor 353
Cambridge 348
Wilmington 313
Beijing 244
Council Bluffs 230
Roxbury 175
Lawrence 174
Nanjing 172
Lauterbourg 156
Dearborn 142
Des Moines 114
New York 113
Rome 109
Los Angeles 103
Boardman 97
Helsinki 94
Dallas 93
Santa Clara 78
São Paulo 75
Brooklyn 67
Bari 65
Columbus 60
Ho Chi Minh City 60
San Diego 52
Buffalo 48
Princeton 46
Hebei 44
Hanoi 42
Munich 42
London 40
Shenyang 39
Inglewood 36
Jiaxing 35
Chicago 33
Jakarta 33
Turin 33
Tokyo 32
Dublin 31
Figino 29
Rio de Janeiro 29
Dong Ket 28
Nanchang 28
Orem 27
Atlanta 25
Brussels 24
Abidjan 23
Hefei 23
Changsha 22
Tashkent 22
Baghdad 21
Johannesburg 21
Taranto 21
Phoenix 20
Turi 20
Belo Horizonte 19
Frankfurt am Main 19
Moscow 19
Paris 18
Warsaw 18
Guangzhou 17
Pune 17
Curitiba 16
Denver 16
Kunming 16
Tianjin 16
Toronto 16
Mexico City 15
Olomouc 15
Dhaka 14
Jinan 14
Montreal 14
Nuremberg 14
Redwood City 14
Stockholm 14
Brasília 13
Guayaquil 13
Istanbul 13
Mottola 13
New Delhi 13
Boston 12
Salvador 12
San Francisco 12
Bogotá 11
Chennai 11
Haiphong 11
Jeddah 11
Las Vegas 11
Porto Alegre 11
Totale 12.802
Nome #
An electronic nose distinguishes exhaled breath of patients with Malignant Pleural Mesothelioma from controls 269
Voluntary lung function screening to reveal new COPD cases in southern Italy 257
Correction of intermittent hypoxia reduces inflammation in obese subjects with obstructive sleep apnea 224
Analysis of aortic remodeling and stiffness in patients with obstructive sleep apnea syndrome: Preliminary results 207
An Electronic Nose Discriminates between the Exhaled Breath of Patients with Pleural Malignant Mesothelioma and Healthy Controls, 192
Clinical and Functional Lung Parameters Associated With Frequent Exacerbator Phenotype in Subjects With Severe COPD 187
Acute parenchymal lung involvement in a 68-year-old woman with systemic lupus erythematosus, anemia, and thrombocytopenia 181
Sniff nasal inspiratory pressure as a prognostic factor of tracheostomy or death in amyotrophic lateral sclerosis 180
An electronic nose in the discrimination of obese patients with and without obstructive sleep apnoea 178
Assessment of Induced Sputum Cellularity in COPD Patients Belonging to Two Different Classes of Air Pollution Exposure 175
Echocardiographic findings and plasma endothelin-1 levels in obese patients with and without obstructive sleep apnea 172
Enviromental Asbestos Exposure as a Risk Factor for Small Airways Obstruction 168
And the patient said: Let me be able to breathe and dream 166
Correlations between severity of obstructive sleep apnoea and systolic pulmonary artery pressure: preliminary results 164
Evaluation of endothelial function and cardiovascular risk in non-obese patients with slight degree of obstructive sleep apnea syndrome 161
Influence of age and gender on the profile of exhaled volatile organic compounds analyzed by an electronic nose 159
A case of cryptogenic organizing pneumonia occurring in Crohn's disease 159
Obstructive Sleep Apnea, Hypertension, and Their Additive Effects on Atherosclerosis 155
Everolimus-induced epithelial to mesenchymal transition (EMT) in bronchial/pulmonary cells: when the dosage does matter in transplantation 153
Ovarian cycle may influence the exhaled volatile organic compounds profile analyzed by an electronic nose 150
Enviromental asbestos exposure as a risk factor for small airways obstruction 147
Does Nocturnal Hypoventilation Have a Protective Effect on Cardiovascular Comorbidity in Obesity Hypoventilation Syndrome? 147
The role of education in the self-compilation of Epworth sleepiness scale questionnaire in patients with suspected obstructive sleep apnea 146
A Portable Device as Sleep-Screening Tool in the Identification of Obstructive Sleep Apnea in Chronic Heart Failure: Which Value Should We Consider as Cutoff? 145
Comment on: Hostettler K, et al. Bosentan for patients with steroid-resistant pulmonary sarcoidosis: a randomised controlled trial 145
The importance of maintaining the same order of performance of lung function and SNIP tests in patients with amyotrophic lateral sclerosis 144
Atrial flutter regression in HIV-associated pulmonary arterial hypertension after treatment with bosentan 143
Nocturnal Hypoventilation May Have a Protective Effect on Ischemic Heart Disease in Patients with Obesity Hypoventilation Syndrome 143
A new approach for the assessment of sleepiness and predictivity of obstructive sleep apnea in drivers: A pilot study 142
An electronic nose may sniff out amyotrophic lateral sclerosis 138
Association between low sniff nasal-inspiratory pressure (SNIP) and sleep disordered breathing in amyotrophic lateral sclerosis: Preliminary results. 135
An electronic nose distinguishes the exhaled breath of obese patients with obstructive sleep apnoea (OSA) from subjects with a similar body mass index and without OSA 134
An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD 134
A60 antigen, as a new tuberculin 133
Alterazioni del metabolismo dell'endotelina-1 in pazienti con tromboembolia polmonare 133
Exhaled breath profiling in patients with COPD and OSA overlap syndrome: A pilot study 133
In vitro identification of new transcriptomic and miRNomic profiles associated with pulmonary fibrosis induced by high doses everolimus: Looking for new pathogenetic markers and therapeutic targets 133
Using PaCO2 values to grade obesity-hypoventilation syndrome severity: a retrospective study 133
Lack of association between OSAS and Hypothyroidism 131
Endogenous heme oxygenase prevents impairment of cerebral vascular functions caused by seizures 129
An electronic nose discriminates exhaled breath of patients with untreated Pulmonary Sarcoidosis from controls 127
Exhaled breath profiling by electronic nose enabled discrimination of allergic rhinitis and extrinsic asthma 127
TITRATION EFFECTIVENESS OF TWO AUTOCPAP DEVICES DRIVEN BY DIFFERENT ALGORITHMS IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA 125
Electronic Nose Technology in Respiratory Diseases 124
Epileptic seizures cause extended postictal cerebral vascular dysfunction that is prevented by HO-1 overexpression 123
Bilateral diaphragmatic paralysis after kidney surgery 123
24-hours Endothelin-1 urinary excretion in patients with Interstitial Lung Disease 122
Increased IL-6 and IL-4 in exhaled breath condensate of patients with nasal polyposis 121
Severe obstructive sleep apnoea exacerbates the microvascular impairment in very mild hypertensives 121
Smoking Habit in Severe Obese after bariatric procedures. 121
The Prognostic Role of Obstructive Sleep Apnea at the Onset of Amyotrophic Lateral Sclerosis 120
Increased 24-hour endothelin-1 urinary excretion in patients with chronic obstructive pulmonary disease. 119
Influence of subclinical hypothyroidism and T4 treatment on the prevalence and severity of obstructive sleep apnoea syndrome (OSAS) 119
Sniff Nasal Pressure Is a Sensitive Marker of Poor Outcome in Amyotrophic Lateral Sclerosis 118
Incidence of deep venous thrombosis in patients with both pulmonary embolism and copd 118
Home Unattended Portable Monitoring and AutoCPAP Titration In Patients With High Risk for Moderate to Severe OSA. 117
Is obstructive sleep apnoea a comorbidity of COPD and is it involved in chronic systemic inflammatory syndrome? 115
HIGH DOSES OF M-TOR INHIBITORS MAY INDUCE PULMONARY PRO-FIBROTIC EFFECTS IN RENAL TRANSPLANT RECIPIENTS: RESULT OF A TRANSLATIONAL COMPARATIVE RESEARCH APPROACH BETWEEN PROGRAF VERSUS EVEROLIMUS 115
Abnormalities of Endothelin-1 metabolism in Pulmonary Embolism 114
Predictive equations for CPAP titration in OSAS patients 114
Clinical variability of respiratory pulmonary hypertension: implications for diagnosis and management 114
Is there a correlation between OSAS duration/severity and carotid intima-media thickness? 113
Evaluation of a transcutaneous carbon dioxide monitor in severe obesity 112
Body mass index, airflow obstruction, dyspnea, and exercise index is not modified after 6 months therapy with roflumilast in a cohort of patients with chronic obstructive pulmonary disease 112
EVEROLIMUS-INDUCED EPITHELIAL TO MESENCHYMAL TRANSITION IN BRONCHIAL AND PULMONARY CELLS: WHEN THE DOSAGE DOES MATTER IN TRANSPLANTATION 111
Hyperventilation In Patients With Pulmonary Arterial Hypertension Is Related To Increased Chemosensitivity 110
An electronic nose in the diagnostic assessment of asthma in pediatric patients 110
Efficacy of positional therapy in treatment of patients with obstructive sleep apnea: a pilot study 110
Correlation between pulse transit time and microvascular impairment in OSAS patients 109
Effect of zafirlukast on methacholine and ultrasonically nebulized distilled water challenge in patients with mild asthma. 109
CD8+ T-cell alveolitis in familial pulmonary alveolar microlithiasis 107
Early treatment with noninvasive positive pressure ventilation prolongs survival in Amyotrophic Lateral Sclerosis patients with nocturnal respiratory insufficiency 107
Role of plasmatic leptin in response to hypercapnia in obese patients with or without osas 106
Heme oxygenase inhibition reduces neuronal activation evoked by bicuculline in newborn pigs. 105
Interleukin-8 and soluble intercellular adhesion molecule 1 during acute respiratory distress syndrome and in response to prolonged methylprednisolone treatment 104
End points for pulmonary arterial hypertension: a way backward. 104
Zafirlukast single oral dose pre-treatment prevents FEV1 drop after bronchial challenge in mild asthma 104
Exhaled Volatile Organic Compounds analysis by e-nose can detect Idiopathic Pulmonary Fibrosis 103
Influence of obstructive sleep apnea on endothelial function in obese patients. 102
Excessive daytime sleepiness in women without OSA 102
Could neutrophilic airway inflammation in obese people be more due to obstructive sleep apnoea syndrome than to asthma? 102
Failure of noninvasive ventilation during hypercapnic exacerbation of chronic obstructive pulmonary disease: the role of chronic kidney diseases 102
Reversibility of the endothelial dysfunction after CPAP therapy in OSAS patients 102
Aumento dell'escrezione urinaria di Endotelina-1 in pazienti affetti da BPCO 98
Is there a correlation between OSAS duration/severity and carotid intima-media thickness? 98
La presenza di apnea notturna peggiora il danno microcircolatorio sin dalle prime fasi dell'ipertensione arteriosa 97
Endogenous heme oxygenase prevents impairment of cerebral vascular functions caused by seizures. 96
Exhaled breath condensate as matrix for toluene detection: a preliminary study 96
Long-term evaluation of mental fatigue by Maastricht Questionnaire in patients with OSAS treated with CPAP 96
Correlation between sniff nasal inspiratory pressure (snip) and amyotrophic lateral sclerosis functional rating scale (alsfrs) in als patients 94
Use of the exhaled breath condensate in the study of airway inflammation after hypertonic saline challenge 94
HPV16 E7-dependent transformation activates NHE1 through a PKA-RhoA-induced inhibition of p38alpha 94
Lower SNIP value is correlated to the need of intubation in Amyotrophic Lateral Sclerosis 93
Noninvasive ventilation (NIV) in the management of chronic heart failure (CHF) 93
Endogenous Endothelin-1 production/excretion in patients with COPD 92
Disfunzione endoteliale nella malattia vascolare polmonare ipossica 91
A successfully home-treated adverse reaction to cefepime in a geriatric patient 90
Cerebral heme-heme oxygenase-carbon monoxide-bilirubin system protects cerebral microvessels during seizures 90
Early and late failure of noninvasive ventilation in chronic obstructive pulmonary disease with acute exacerbation 90
ET-1 induces mitogenesis in ovine airway smooth muscle cells via ETA and ETB receptors. 90
Totale 12.880
Categoria #
all - tutte 79.501
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.501


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022970 0 0 5 89 49 76 40 67 75 56 170 343
2022/20231.952 266 185 120 204 259 300 17 197 337 8 26 33
2023/2024610 51 124 38 43 67 136 37 31 4 19 4 56
2024/20252.629 41 33 246 75 48 212 177 245 132 123 410 887
2025/20265.656 812 257 268 553 626 295 634 155 594 535 194 733
2026/2027710 141 298 271 0 0 0 0 0 0 0 0 0
Totale 19.005